Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ferrante

Showing results (231-240 of 350) with videos related to

Pageof 35
Sort By:
Frontiers in Immunology|March 20, 2023
SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study - the BELCOMID studyJeroen Geldof, Marie Truyens, João Sabino, et al.
Journal of Crohn'S & Colitis|April 18, 2023
Results of the Eighth Scientific Workshop of ECCO: Prevention and Treatment of Postoperative Recurrence in Patients With Crohn's Disease Undergoing an Ileocolonic Resection With Ileocolonic AnastomosisMarc Ferrante, Lieven Pouillon, Míriam Mañosa, et al.
Journal of Crohn'S & Colitis|June 28, 2015
The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis PatientsTriana Lobatón, Talat Bessissow, Gert De Hertogh, et al.
Gut|April 26, 2007
New serological markers in inflammatory bowel disease are associated with complicated disease behaviourMarc Ferrante, Liesbet Henckaerts, Marie Joossens, et al.
Vaccines|October 26, 2024
Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study)Jeroen Geldof, Marie Truyens, João Sabino, et al.
Frontiers in Pharmacology|March 13, 2026
Inconsistent medication recommendations for immune-mediated inflammatory diseases across pregnancy, lactation, and paternal preconception: a guideline-based reviewElise Van den Broeck, Sien Lenie, Marc Ferrante, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Long-term outcome after infliximab for refractory ulcerative colitisMarc Ferrante, Séverine Vermeire, Herma Fidder, et al.
Gut|July 13, 2017
Chromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trialRaf Bisschops, Talat Bessissow, Joseph A Joseph, et al.
Journal of Crohn'S & Colitis|September 24, 2011
Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel diseaseLaurent Peyrin-Biroulet, Marc Ferrante, Fernando Magro, et al.
Frontiers in Medicine|August 29, 2024
Patient preferences for inflammatory bowel disease treatments: protocol development of a global preference survey using a discrete choice experimentElise Schoefs, Séverine Vermeire, Marc Ferrante, et al.
Pageof 35

Showing results (231-240 of 350) with videos related to

Sort By:
Pageof 35
Frontiers in Immunology|March 20, 2023
SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study - the BELCOMID studyJeroen Geldof, Marie Truyens, João Sabino, et al.
Journal of Crohn'S & Colitis|April 18, 2023
Results of the Eighth Scientific Workshop of ECCO: Prevention and Treatment of Postoperative Recurrence in Patients With Crohn's Disease Undergoing an Ileocolonic Resection With Ileocolonic AnastomosisMarc Ferrante, Lieven Pouillon, Míriam Mañosa, et al.
Journal of Crohn'S & Colitis|June 28, 2015
The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis PatientsTriana Lobatón, Talat Bessissow, Gert De Hertogh, et al.
Gut|April 26, 2007
New serological markers in inflammatory bowel disease are associated with complicated disease behaviourMarc Ferrante, Liesbet Henckaerts, Marie Joossens, et al.
Vaccines|October 26, 2024
Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study)Jeroen Geldof, Marie Truyens, João Sabino, et al.
Frontiers in Pharmacology|March 13, 2026
Inconsistent medication recommendations for immune-mediated inflammatory diseases across pregnancy, lactation, and paternal preconception: a guideline-based reviewElise Van den Broeck, Sien Lenie, Marc Ferrante, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Long-term outcome after infliximab for refractory ulcerative colitisMarc Ferrante, Séverine Vermeire, Herma Fidder, et al.
Gut|July 13, 2017
Chromoendoscopy versus narrow band imaging in UC: a prospective randomised controlled trialRaf Bisschops, Talat Bessissow, Joseph A Joseph, et al.
Journal of Crohn'S & Colitis|September 24, 2011
Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel diseaseLaurent Peyrin-Biroulet, Marc Ferrante, Fernando Magro, et al.
Frontiers in Medicine|August 29, 2024
Patient preferences for inflammatory bowel disease treatments: protocol development of a global preference survey using a discrete choice experimentElise Schoefs, Séverine Vermeire, Marc Ferrante, et al.
Pageof 35